Krsnaa Diagnostics Limited (KRSNAA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.056x

Based on the latest financial reports, Krsnaa Diagnostics Limited (KRSNAA) has a cash flow conversion efficiency ratio of 0.056x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs518.74 Million ≈ $5.61 Million USD) by net assets (Rs9.23 Billion ≈ $99.81 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Krsnaa Diagnostics Limited market cap and net worth for the company's overall valuation and market capitalisation.

Krsnaa Diagnostics Limited - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Krsnaa Diagnostics Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Krsnaa Diagnostics Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Krsnaa Diagnostics Limited ranked by their cash flow conversion efficiency. Explore Krsnaa Diagnostics Limited cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
AK Sigorta AS
IS:AKGRT
0.178x
Columbus A/S
CO:COLUM
0.010x
Stic Investments Inc
KO:026890
0.005x
Ontex Group NV
BR:ONTEX
0.072x
Allpark Empreendimentos Participações e Serviços S.A
SA:ALPK3
1.176x
Sinphar Pharmaceutical Co Ltd
TW:1734
0.031x
SWK Holdings Corp
NASDAQ:SWKH
0.004x
Ramada Investimentos e Industria S.A
LS:RAM
0.094x

Annual Cash Flow Conversion Efficiency for Krsnaa Diagnostics Limited (2017–2025)

The table below shows the annual cash flow conversion efficiency of Krsnaa Diagnostics Limited from 2017 to 2025. View KRSNAA share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs8.83 Billion
≈ $95.47 Million
Rs873.27 Million
≈ $9.44 Million
0.099x +229.06%
2024-03-31 Rs8.10 Billion
≈ $87.58 Million
Rs243.45 Million
≈ $2.63 Million
0.030x -70.89%
2023-03-31 Rs7.39 Billion
≈ $79.89 Million
Rs763.01 Million
≈ $8.25 Million
0.103x -46.22%
2022-03-31 Rs6.69 Billion
≈ $72.32 Million
Rs1.28 Billion
≈ $13.89 Million
0.192x -56.58%
2021-03-31 Rs2.32 Billion
≈ $25.08 Million
Rs1.03 Billion
≈ $11.09 Million
0.442x +330.44%
2020-03-31 Rs-1.97 Billion
≈ $-21.30 Million
Rs378.09 Million
≈ $4.09 Million
-0.192x +72.02%
2019-03-31 Rs-849.21 Million
≈ $-9.18 Million
Rs582.66 Million
≈ $6.30 Million
-0.686x +52.08%
2018-03-31 Rs-228.96 Million
≈ $-2.48 Million
Rs327.85 Million
≈ $3.55 Million
-1.432x -274.29%
2017-03-31 Rs757.06 Million
≈ $8.19 Million
Rs621.99 Million
≈ $6.73 Million
0.822x --

About Krsnaa Diagnostics Limited

NSE:KRSNAA India Diagnostics & Research
Market Cap
$192.40 Million
Rs17.79 Billion INR
Market Cap Rank
#16770 Global
#874 in India
Share Price
Rs548.45
Change (1 day)
-0.51%
52-Week Range
Rs520.30 - Rs832.45
All Time High
Rs1020.15
About

Krsnaa Diagnostics Limited provides diagnostic services in India. It offers a range radiology services, including computed tomography scans, magnetic resonance imaging, X-rays, and ultrasound and advanced imaging; pathology services, such as laboratory, and home collection and preventive health; and teleradiology and telepathology services. The company also provides other diagnostics services, su… Read more